268 related articles for article (PubMed ID: 31548349)
1. Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance).
Yuan C; Sato K; Hollis BW; Zhang S; Niedzwiecki D; Ou FS; Chang IW; O'Neil BH; Innocenti F; Lenz HJ; Blanke CD; Goldberg RM; Venook AP; Mayer RJ; Fuchs CS; Meyerhardt JA; Ng K
Clin Cancer Res; 2019 Dec; 25(24):7497-7505. PubMed ID: 31548349
[TBL] [Abstract][Full Text] [Related]
2. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
Ng K; Nimeiri HS; McCleary NJ; Abrams TA; Yurgelun MB; Cleary JM; Rubinson DA; Schrag D; Miksad R; Bullock AJ; Allen J; Zuckerman D; Chan E; Chan JA; Wolpin BM; Constantine M; Weckstein DJ; Faggen MA; Thomas CA; Kournioti C; Yuan C; Ganser C; Wilkinson B; Mackintosh C; Zheng H; Hollis BW; Meyerhardt JA; Fuchs CS
JAMA; 2019 Apr; 321(14):1370-1379. PubMed ID: 30964527
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741.
Ng K; Sargent DJ; Goldberg RM; Meyerhardt JA; Green EM; Pitot HC; Hollis BW; Pollak MN; Fuchs CS
J Clin Oncol; 2011 Apr; 29(12):1599-606. PubMed ID: 21422438
[TBL] [Abstract][Full Text] [Related]
4. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer.
Ng K; Meyerhardt JA; Wu K; Feskanich D; Hollis BW; Giovannucci EL; Fuchs CS
J Clin Oncol; 2008 Jun; 26(18):2984-91. PubMed ID: 18565885
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer.
Ng K; Wolpin BM; Meyerhardt JA; Wu K; Chan AT; Hollis BW; Giovannucci EL; Stampfer MJ; Willett WC; Fuchs CS
Br J Cancer; 2009 Sep; 101(6):916-23. PubMed ID: 19690551
[TBL] [Abstract][Full Text] [Related]
6. IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405.
Guercio BJ; Zhang S; Ou FS; Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Pollak MN; Nixon AB; Mullen BC; O'Neil BH; Shaw JE; Polite BN; Benson AB; Atkins JN; Goldberg RM; Brown JC; O'Reilly EM; Mayer RJ; Blanke CD; Fuchs CS; Meyerhardt JA
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426464
[TBL] [Abstract][Full Text] [Related]
7. Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance).
Fuchs MA; Yuan C; Sato K; Niedzwiecki D; Ye X; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Innocenti F; Warren RS; Bertagnolli MM; Ogino S; Giovannucci EL; Horvath E; Meyerhardt JA; Ng K
Ann Oncol; 2017 Jun; 28(6):1359-1367. PubMed ID: 28327908
[TBL] [Abstract][Full Text] [Related]
8. Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.
Fedirko V; Riboli E; Tjønneland A; Ferrari P; Olsen A; Bueno-de-Mesquita HB; van Duijnhoven FJ; Norat T; Jansen EH; Dahm CC; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Racine A; Lukanova A; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Benetou V; Trichopoulos D; Grioni S; Vineis P; Panico S; Palli D; Tumino R; Siersema PD; Peeters PH; Skeie G; Brustad M; Chirlaque MD; Barricarte A; Ramón Quirós J; Sánchez MJ; Dorronsoro M; Bonet C; Palmqvist R; Hallmans G; Key TJ; Crowe F; Khaw KT; Wareham N; Romieu I; McKay J; Wark PA; Romaguera D; Jenab M
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):582-93. PubMed ID: 22278364
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of circulating vitamin D binding protein, total, free and bioavailable 25-hydroxy vitamin D in patients with colorectal cancer.
Yang L; Chen H; Zhao M; Peng P
Oncotarget; 2017 Jun; 8(25):40214-40221. PubMed ID: 28388568
[TBL] [Abstract][Full Text] [Related]
10. Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D
Yuan C; Renfro L; Ambadwar PB; Ou FS; McLeod HL; Innocenti F; Meyerhardt JA; Wolpin BM; Goldberg RM; Grothey A; Fuchs CS; Ng K
Cancer Causes Control; 2019 Jul; 30(7):757-765. PubMed ID: 31104167
[TBL] [Abstract][Full Text] [Related]
11. 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance).
Van Loon K; Owzar K; Jiang C; Kindler HL; Mulcahy MF; Niedzwiecki D; O'Reilly EM; Fuchs C; Innocenti F; Venook AP;
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25099612
[TBL] [Abstract][Full Text] [Related]
12. Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance).
Wang QL; Ma C; Yuan C; Shi Q; Wolpin BM; Zhang Y; Fuchs CS; Meyer J; Zemla T; Cheng E; Kumthekar P; Guthrie KA; Couture F; Kuebler P; Kumar P; Tan B; Krishnamurthi S; Goldberg RM; Venook A; Blanke C; Shields AF; O'Reilly EM; Meyerhardt JA; Ng K
Clin Cancer Res; 2023 Jul; 29(14):2621-2630. PubMed ID: 37289007
[TBL] [Abstract][Full Text] [Related]
13. Association of prediagnostic vitamin D status with mortality among colorectal cancer patients differs by common, inherited vitamin D-binding protein isoforms.
Gibbs DC; Bostick RM; McCullough ML; Um CY; Flanders WD; Jenab M; Weiderpass E; Gylling B; Gram IT; Heath AK; Colorado-Yohar S; Dahm CC; Bueno-de-Mesquita B; Perez-Cornago A; Trichopoulou A; Tumino R; Kühn T; Fedirko V
Int J Cancer; 2020 Nov; 147(10):2725-2734. PubMed ID: 32391587
[TBL] [Abstract][Full Text] [Related]
14. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931).
Snyder RA; He J; Le-Rademacher J; Ou FS; Dodge AB; Zemla TJ; Paskett ED; Chang GJ; Innocenti F; Blanke C; Lenz HJ; Polite BN; Venook AP
Cancer; 2021 Oct; 127(20):3801-3808. PubMed ID: 34374082
[TBL] [Abstract][Full Text] [Related]
16. Effects of Circulating 25(OH)D Status in Advanced Colorectal Cancer Patients Undergoing Chemotherapy: A Systematic Review.
Zeng X; Zhang L; Jia S; Lin T; Liu G; Yue J; Huang X
Anticancer Res; 2021 Dec; 41(12):5903-5912. PubMed ID: 34848444
[TBL] [Abstract][Full Text] [Related]
17. Association of Circulating 25-Hydroxyvitamin D Levels with Colorectal Cancer: An Updated Meta-Analysis.
Xu J; Yuan X; Tao J; Yu N; Wu R; Zhang Y
J Nutr Sci Vitaminol (Tokyo); 2018; 64(6):432-444. PubMed ID: 30606966
[TBL] [Abstract][Full Text] [Related]
18. Relationship of very low serum 25-hydroxyvitamin D
Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
[TBL] [Abstract][Full Text] [Related]
19. Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies.
Kelly JL; Salles G; Goldman B; Fisher RI; Brice P; Press O; Casasnovas O; Maloney DG; Soubeyran P; Rimsza L; Haioun C; Xerri L; LeBlanc M; Tilly H; Friedberg JW
J Clin Oncol; 2015 May; 33(13):1482-90. PubMed ID: 25823738
[TBL] [Abstract][Full Text] [Related]
20. Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405.
Guercio BJ; Zhang S; Ou FS; Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; O'Neil BH; Shaw JE; Polite BN; Hochster HS; Atkins JN; Goldberg RM; Sato K; Ng K; Van Blarigan E; Mayer RJ; Blanke CD; O'Reilly EM; Fuchs CS; Meyerhardt JA
J Clin Oncol; 2019 Oct; 37(29):2620-2631. PubMed ID: 31408415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]